COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 889 | 12 | 626 | 83 | 1011 | 171 | 1041 |
ERLYTX | 90 | 1 | 52 | 11 | 134 | 20 | 122 |
GI | 193 | 3 | 157 | 14 | 170 | 26 | 158 |
GU | 457 | 4 | 209 | 18 | 219 | 48 | 292 |
LEUK | 114 | 1 | 52 | 9 | 110 | 20 | 122 |
LUNG | 356 | 5 | 261 | 19 | 231 | 37 | 225 |
LYMPH | 348 | 7 | 365 | 27 | 329 | 59 | 359 |
MELAN | 414 | 1 | 52 | 21 | 256 | 68 | 414 |
MMYEL | 234 | 1 | 52 | 12 | 146 | 23 | 140 |
MULT | 3 | 0 | 0 | 0 | 0 | 1 | 6 |
OTHER | 34 | 2 | 104 | 6 | 73 | 9 | 55 |
PREV | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
SXQOL | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3142 | 37 | 1930 | 220 | 2679 | 482 | 2934 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
1 | 1 | 52 | 1 | 12 | 1 | 6 | |
CCD | 277 | 2 | 104 | 5 | 61 | 12 | 73 |
ERLYTX | 9 | 1 | 52 | 1 | 12 | 2 | 12 |
GU | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
LEUK | 654 | 9 | 470 | 55 | 670 | 105 | 639 |
LUNG | 261 | 6 | 313 | 38 | 463 | 67 | 408 |
OTHER | 26 | 2 | 104 | 4 | 49 | 9 | 55 |
PEOLC | 71 | 3 | 157 | 13 | 158 | 25 | 152 |
PREV | 299 | 3 | 157 | 19 | 231 | 38 | 231 |
SURV | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 616 | 10 | 522 | 49 | 597 | 87 | 530 |
Total | 2223 | 37 | 1931 | 187 | 2277 | 350 | 2130 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
1 | 1 | 52 | 1 | 12 | 1 | 6 | |
BREAST | 889 | 12 | 626 | 83 | 1011 | 171 | 1041 |
CCD | 277 | 2 | 104 | 5 | 61 | 12 | 73 |
ERLYTX | 99 | 2 | 104 | 12 | 146 | 22 | 134 |
GI | 193 | 3 | 157 | 14 | 170 | 26 | 158 |
GU | 458 | 4 | 209 | 18 | 219 | 48 | 292 |
LEUK | 768 | 10 | 522 | 64 | 779 | 125 | 761 |
LUNG | 617 | 11 | 574 | 57 | 694 | 104 | 633 |
LYMPH | 348 | 7 | 365 | 27 | 329 | 59 | 359 |
MELAN | 414 | 1 | 52 | 21 | 256 | 68 | 414 |
MMYEL | 234 | 1 | 52 | 12 | 146 | 23 | 140 |
MULT | 3 | 0 | 0 | 0 | 0 | 1 | 6 |
OTHER | 60 | 4 | 209 | 10 | 122 | 18 | 110 |
PEOLC | 71 | 3 | 157 | 13 | 158 | 25 | 152 |
PREV | 304 | 3 | 157 | 19 | 231 | 38 | 231 |
SURV | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 621 | 10 | 522 | 49 | 597 | 87 | 530 |
Total | 5365 | 74 | 3862 | 407 | 4955 | 832 | 5064 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 536 | 8 | 417 | 47 | 572 | 101 | 615 |
ERLYTX | 49 | 0 | 0 | 6 | 73 | 7 | 43 |
GI | 148 | 3 | 157 | 12 | 146 | 20 | 122 |
GU | 396 | 3 | 157 | 14 | 170 | 39 | 237 |
LEUK | 75 | 1 | 52 | 5 | 61 | 14 | 85 |
LUNG | 217 | 4 | 209 | 13 | 158 | 25 | 152 |
LYMPH | 228 | 4 | 209 | 18 | 219 | 39 | 237 |
MELAN | 254 | 0 | 0 | 13 | 158 | 46 | 280 |
MMYEL | 150 | 1 | 52 | 7 | 85 | 17 | 103 |
MULT | 2 | 0 | 0 | 0 | 0 | 1 | 6 |
OTHER | 34 | 2 | 104 | 6 | 73 | 9 | 55 |
PREV | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
SXQOL | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2099 | 26 | 1357 | 141 | 1715 | 318 | 1935 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
1 | 1 | 52 | 1 | 12 | 1 | 6 | |
CCD | 232 | 1 | 52 | 4 | 49 | 11 | 67 |
ERLYTX | 9 | 1 | 52 | 1 | 12 | 2 | 12 |
GU | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
LEUK | 293 | 4 | 209 | 26 | 317 | 52 | 317 |
LUNG | 153 | 4 | 209 | 24 | 292 | 44 | 268 |
OTHER | 26 | 2 | 104 | 4 | 49 | 9 | 55 |
PEOLC | 46 | 3 | 157 | 8 | 97 | 16 | 97 |
PREV | 299 | 3 | 157 | 19 | 231 | 38 | 231 |
SURV | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 418 | 9 | 470 | 38 | 463 | 61 | 371 |
Total | 1486 | 28 | 1462 | 127 | 1546 | 238 | 1448 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
1 | 1 | 52 | 1 | 12 | 1 | 6 | |
BREAST | 717 | 10 | 522 | 57 | 694 | 127 | 773 |
CCD | 259 | 1 | 52 | 4 | 49 | 11 | 67 |
ERLYTX | 58 | 1 | 52 | 7 | 85 | 9 | 55 |
GI | 153 | 3 | 157 | 14 | 170 | 22 | 134 |
GU | 413 | 3 | 157 | 19 | 231 | 46 | 280 |
LEUK | 368 | 5 | 261 | 31 | 377 | 66 | 402 |
LUNG | 371 | 8 | 417 | 37 | 450 | 69 | 420 |
LYMPH | 228 | 4 | 209 | 18 | 219 | 39 | 237 |
MELAN | 254 | 0 | 0 | 13 | 158 | 46 | 280 |
MMYEL | 149 | 1 | 52 | 7 | 85 | 17 | 103 |
MULT | 8 | 1 | 52 | 2 | 24 | 6 | 37 |
OTHER | 222 | 5 | 261 | 21 | 256 | 43 | 262 |
PEOLC | 54 | 2 | 104 | 4 | 49 | 9 | 55 |
PREV | 304 | 3 | 157 | 19 | 231 | 38 | 231 |
SURV | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 423 | 9 | 470 | 38 | 463 | 61 | 371 |
Total | 3990 | 57 | 2975 | 294 | 3577 | 614 | 3737 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 779 | 10 | 522 | 73 | 889 | 147 | 895 |
ERLYTX | 88 | 1 | 52 | 11 | 134 | 20 | 122 |
GI | 100 | 2 | 104 | 9 | 110 | 15 | 91 |
GU | 232 | 2 | 104 | 14 | 170 | 33 | 201 |
LEUK | 82 | 0 | 0 | 6 | 73 | 13 | 79 |
LUNG | 326 | 5 | 261 | 18 | 219 | 30 | 183 |
LYMPH | 277 | 7 | 365 | 25 | 304 | 52 | 317 |
MMYEL | 218 | 0 | 0 | 10 | 122 | 20 | 122 |
MULT | 3 | 0 | 0 | 0 | 0 | 1 | 6 |
Total | 2105 | 27 | 1408 | 166 | 2021 | 331 | 2016 |
Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
Member | 1996 | 28 | 1461 | 147 | 1790 | 323 | 1966 |
AFFIL | 159 | 4 | 209 | 16 | 195 | 26 | 158 |
CCOP/NCORP | 1430 | 22 | 1148 | 105 | 1278 | 207 | 1260 |
Non-SWOG | 1780 | 20 | 1044 | 139 | 1692 | 276 | 1680 |
Total | 5365 | 74 | 3862 | 407 | 4955 | 832 | 5064 |
ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
---|---|---|---|---|---|
GU | S2427 | Blad, MIBC, RT + Pembrolizumab | 1 | Y | 04-SEP-25 |
ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
---|---|---|---|---|---|
CCD | A191901 | Brst, Text/Motivational Intervention ET Adher | 1 | E | 31-AUG-25 |
MELAN | S2015 | MELAN, Stg I-II, 1cm v 2cm excision margins | 1 | E | 28-AUG-25 |
GU | NRGGU009 | Pros, PREDICT-RT | 1 | E | 18-AUG-25 |
GU | NRGGU009 | Pros, PREDICT-RT | 2 | E | 18-AUG-25 |
BREAST | EA1211 | Breast, HER2+, NeoAdj Therapy | 1 | E | 15-AUG-25 |
MELAN | EA6192 | Melan, Adv, Erly Discont of Antibdy Thrpy | 0 | E | 03-SEP-25 |
MELAN | EA6192 | Melan, Adv, Erly Discont of Antibdy Thrpy | 1 | E | 03-SEP-25 |
ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
---|---|---|---|---|
LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 9 |
BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 9 |
BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 7 |
LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 6 |
LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 4 |